Based on these results, we hypothesize that the contact response and disturbed barrier induced by dithranol leads via a vicious loop between AMPs and cytokines such as IL‐1β to an immune suppressive environment in the skin, possibly being beneficial in alopecia areata. The gene discussed is IL1B; the disease is alopecia areata.